Eribulin, a synthetic analog of the marine sponge natural product halichondrin B [5], is an MT dynamics inhibitor with both cytotoxic antimitotic mechanisms [6,7] and noncytotoxic effects on tumor vasculature, tumor phenotype and the tumor immune landscape [8,9,10,11,12,13]. The gene discussed is MCAT; the disease is neoplasm.